Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

Entity

Alector Brain Carrier

technology2 mentionslast seen Oct 16, 2026

Proprietary blood-brain barrier delivery platform for transporting therapeutics across the blood-brain barrier.

Relationships 3

Alector Brain Carrier

Relationship

AL050depends onAlector Brain Carrier

96% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1

filingSEC EDGAROct 5, 2026Alector, Inc. 8-K: Item 1.01: Entry into a Material Definitive Agreement; Item 2.02: Results of Operations and Financial Condition; Item 7.01: Regulation FD Disclosure; Item 8.01: Other Events; Item 9.01: Financial Statements and Exhibits
AL050 is designed to address GCase deficiency, a driver of neurodegeneration in Parkinson's Disease that is most pronounced in – but not limited to – carriers of GBA1 mutations. It combines an Alector-engineered GCase, optimized for greater enzymatic activity and a longer half-life, with Alector's ABC, which is designed to transport therapeutics across the blood-brain barrier.